Evidence map›Paper›PMID 33038259›Full record

ArticleInternational immunology2021

Selective expression of claudin-5 in thymic endothelial cells regulates the blood-thymus barrier and T-cell export.

Takahiro Nagatake, Yan-Chun Zhao, Takeshi Ito, Masahiko Itoh, Kohei Kometani, Mikio Furuse, Azusa Saika, Eri Node, Jun Kunisawa, Nagahiro Minato and 1 more

Open access · hybridAbstract read
In one paragraph

Article in International immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Mesenchymal stromal cells in the thymus.Inflammation and regeneration · 2022
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Takahiro NagatakeDepartment of Immunology and Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yan-Chun ZhaoGraduate School of Biostudies, Kyoto University, Kyoto, Japan.
Takeshi ItoDepartment of Immunology and Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Masahiko ItohDepartment of Biochemistry, School of Medicine, Dokkyo Medical University, Tochigi, Japan.
Kohei KometaniLaboratory of Immunobiology, Graduate School of Medicine, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
Mikio FuruseDivision of Cell Structure, National Institute for Physiological Sciences, Okazaki, Aichi, Japan.
Azusa SaikaLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.
Eri NodeLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.
Jun KunisawaLaboratory of Vaccine Materials, Center for Vaccine and Adjuvant Research and Laboratory of Gut Environmental System, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.
Nagahiro MinatoDepartment of Immunology and Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yoko HamazakiDepartment of Immunology and Cell Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kyoto University · JPNational Institute of Biomedical Innovation, Health and Nutrition · JPDokkyo Medical University · JPNational Institute for Physiological Sciences · JPOsaka University of Pharmaceutical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T-cell development depends on the thymic microenvironment, in which endothelial cells (ECs) play a vital role. Interestingly, vascular permeability of the thymic cortex is lower than in other organs, suggesting the existence of a blood-thymus barrier (BTB). On the other hand, blood-borne molecules and dendritic cells bearing self-antigens are accessible to the medulla, facilitating central tolerance induction, and continuous T-precursor immigration and mature thymocyte egress occur through the vessels at the cortico-medullary junction (CMJ). We found that claudin-5 (Cld5), a membrane protein of tight junctions, was expressed in essentially all ECs of the cortical vasculatures, whereas approximately half of the ECs of the medulla and CMJ lacked Cld5 expression. An intravenously (i.v.) injected biotin tracer hardly penetrated cortical Cld5+ vessels, but it leaked into the medullary parenchyma through Cld5- vessels. Cld5 expression in an EC cell line caused a remarkable increase in trans-endothelial resistance in vitro, and the biotin tracer leaked from the cortical vasculatures in Cldn5-/- mice. Furthermore, i.v.-injected sphingosine-1 phosphate distributed selectively into the medulla through the Cld5- vessels, probably ensuring the egress of CD3high mature thymocytes from Cld5- vessels at the CMJ. These results suggest that distinct Cld5 expression profiles in the cortex and medulla may control the BTB and the T-cell gateway to blood circulation, respectively.

Indexed as

AnimalsCapillary PermeabilityCell DifferentiationCell LineClaudin-5Endothelial CellsLysophospholipidsMiceMice, Inbred C57BLMice, KnockoutSphingosineThymocytesThymus GlandTight JunctionsT-LymphocytesClaudin-5Cldn5 protein, mouseLysophospholipidsSphingosinesphingosine 1-phosphateendothelial barriersphingosine-1 phosphatethymustight junction

Identifiers

PMID33038259
PMCPMC7936066
OpenAlexW3092229221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.